|
General Information
|
|
|
Product
|
NAPSIN A Antibody BIOTIN-Conjugated
|
|
Description
|
BIOTIN-Conjugated Napsin A aspartic peptidase Antibody C-epitope
|
|
Verified Applications
|
ELISA, IHC, IP, WB
|
|
Host
|
Rabbit
|
|
Species Cross Reactivity
|
Human, Mouse, Rat
|
|
Immunogen
|
Synthetic peptide taken within amino acid region 250-300 on human Napsin A protein.
|
|
Accession #
|
GenBank: EAW71848.1
|
|
Physical Properties
|
|
|
Quantity
|
100 µg
|
|
Volume
|
200 µl
|
|
Concentration
|
0.85-1.25 µg/µl in antibody stabilization buffer
|
|
Immunoglobulin
|
IgG
|
|
Form
|
BIOTIN-Conjugated
|
|
Clonality
|
Polyclonal
|
|
Determinant
|
C-epitope
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
DB
|
1:10,000
|
|
ELISA
|
1:10,000
|
| Immunohistochemistry |
1:100 |
|
Immunoprecipitation
|
1:200
|
|
Western Blot
|
1:500
|
|
Protein
|
|
Uniprot #
|
O96009
|
|
Overview
|
May be involved in processing of pneumocyte surfactant precursors
|
|
Molecular Function
|
aspartic-type endopeptidase activity; peptidase activity
|
|
Subcellular Location
|
alveolar lamellar body; extracellular space; extracellular vesicular exosome; lysosome
|
|
Expression
|
Expressed predominantly in adult lung (type II pneumocytes) and kidney and in fetal lung. Low levels in adult spleen and very low levels in peripheral blood leukocytes.
|
|
Structure
|
Belongs to the peptidase A1 family.
|
|
Alternative Nomenclature
|
ASP 4 antibody Aspartyl protease 4 antibody
KAP antibody
Kdap antibody
Kidney derived aspartic protease like protein antibody
NAP1 antibody
NAPA antibody
NAPSA antibody
Napsin 1 antibody
napsin A aspartic peptidase antibody Pronapsin A antibody
SNAPA antibody
TA01/TA02 antibody
|
| |
|
NAPSIN A Blocking Peptide
NAPSIN A Antibody
NAPSIN A Antibody FITC
NAPSIN A Positive Control
